World of DTC Marketing
AUGUST 2, 2022
A Gizmodo investigation into some of the nation’s biggest data brokers found more than two dozen promoting access to datasets containing digital information on millions of pregnant and potentially pregnant people across the country. At least one of those companies also offered an extensive catalog of people using birth control targeted by more restrictive states, But is this true?
MedCity News
AUGUST 2, 2022
Summer Health, a telehealth startup that delivers pediatric care via text messaging, launched last week with $7.5 million in seed funding. The seed round was led by Alfred Lin at Sequoia Capital and Deena Shakir at Lux Capital.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
AUGUST 2, 2022
Samsung Biologics and GreenLight Biosciences have completed the initial commercial-scale engineering run for their messenger ribonucleic acid (mRNA) Covid-19 vaccine under their manufacturing collaboration. Last year, the companies entered a strategic collaboration. Subsequently, technology transfer as well as scale-up from the lab bench to the commercial facility of Samsung were carried out in a period of seven months.
MedCity News
AUGUST 2, 2022
Many potential participants are tired and stressed. Research studies need to prioritize simplicity, authenticity, and practicality to earn patient trust for better enrollment and retention.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
AUGUST 2, 2022
Roche’s Tecentriq could become the first drug in the PD-1/PD-L1 inhibitor class to be approved in a subcutaneous formulation, after the new version matched the original intravenous formulation in a phase 3 trial. The results of the IMscin001 study found that an injection of Tecentriq under the skin taking just a few minutes was non-inferior to a 30 to 60-minute infusion with the IV version in terms of pharmacokinetics – how the active ingredient behaves in the body after administration.
Salesforce
AUGUST 2, 2022
Is age part of your equation when you think about diversity, equity and inclusion? It should be, especially now with five generations currently in the workplace. Companies need to meet the needs of this intergenerational workforce, and those that do see a positive impact from age diversity and age-friendly workplaces. According to an AARP survey of corporate executives , 83% reported that a multigenerational workforce was valuable to their organizations’ success and growth.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Scott Burrows
AUGUST 2, 2022
What is Blocking You? As a motivational sales speaker, let me be honest and tell you that beating-up yourself because you didn’t “make your numbers,” probably won’t work. I know that it might be a popular concept, but motivation doesn’t work that way.
MedCity News
AUGUST 2, 2022
Ipsen has been an active dealmaker lately, and it just struck another one that takes the pharmaceutical company into a new area of drug research. The Paris-based company is collaborating with Marengo Therapeutics on the development of two drugs that selectively activate T cells to fight cancer.
Legacy MEDSearch
AUGUST 2, 2022
Cognito Therapeutics , announced that its proprietary gamma sensory stimulation at 40Hz over a 6-month period reduced white matter atrophy in the brain for patients with Alzheimer’s Disease, according to new data presented at the Alzheimer’s Association International Conference 2022. Alzheimer’s Disease (AD) is the most common form of dementia. Although white matter atrophy is observed in normal aging, it is more pronounced in AD patients.
MedCity News
AUGUST 2, 2022
Medically Home partners with health systems to provide care in patients’ homes. As long as there is a roof, electricity, running water and a bathroom, the company can offer its services.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmaTech
AUGUST 2, 2022
The option of using prefilled syringes for vaccinations is not (yet) available for all types of vaccines. Stakeholders are working to expand that option while also pursuing other non-traditional routes of administration.
MedCity News
AUGUST 2, 2022
Digital health startup Lisa Health recently launched Midday, an app it co-developed with Mayo Clinic to help women navigate menopause. The Oakland-based company also announced the close of its $2.5 million oversubscribed seed round led by Radical Ventures.
Clarivate
AUGUST 2, 2022
A new study by the Centre for Innovation in Regulatory Science (CIRS) has shown that the approval times of major global regulatory agencies have reduced and converged over the last decade, though there are still differences between them. Increased collaboration between regulatory agencies also appears to be having a positive impact on the roll out of new drugs.
MedCity News
AUGUST 2, 2022
In the collaboration, AmeriHealth New Jersey will educate its members on the Thyme Care model so they know to access it if they have a cancer diagnosis. Thyme will provide the data analytics on the membership population and offer support throughout members’ care.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
ALULA
AUGUST 2, 2022
Video discussion with John Dale , Global Energy Practice Lead and Brian Cole, Ph.D., Senior Principal. If you checked out the first two posts in our series on leading decarbonization/net-zero work, then you’ve been ramping up your own influence skills and verifying how to assess change in your organization. Still, you know it will take a constellation of effort across teams to make and keep progress steady.
MedCity News
AUGUST 2, 2022
Decentralized clinical trial approaches helped the pharma industry navigate through Covid-19. Now it is becoming increasingly clear that there’s a need for a hybrid approach to decentralized clinical trials that considers the perspectives of patients and the impact to clinical trial sites.
pharmaphorum
AUGUST 2, 2022
According to the World Health Organization (WHO), approximately 296 million people globally live with hepatitis B, with most unaware of their infection. Africa is the worst impacted region for hepatitis B with a prevalence of 7.5 percent compared to 0.5 percent in the Americas. Hepatitis C impacts an estimated 58 million people across the globe. Again, Africa is the worst-impacted region with a prevalence of 0.8 percent while the Americas see a prevalence of 0.5 percent.
MedCity News
AUGUST 2, 2022
Taking inspiration from the success of drug cocktails that halt viral infections, startup IDRx aims to develop cancer drug combinations that stop tumor escape. The company, founded by serial entrepreneur Alexis Borisy, has set gastrointestinal stromal tumor (GIST) as its first disease target.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Copyright Clearance Center
AUGUST 2, 2022
August 2, 2022 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, has contracted with the Chinese Medical Association Publishing House (CMAPH) to offer document delivery and licensing solutions for all CMAPH journals. CMA titles will now be included in the Republication License Service on CCC Marketplace and Document Delivery with RightFind.
European Pharmaceutical Review
AUGUST 2, 2022
GSK has signed a framework contract with the European Commission’s (EC) Health Emergency Preparedness and Response Authority (HERA) for the reservation of future production and supply of 85 million doses of its pandemic influenza vaccine Adjupanrix [pandemic influenza vaccine (split virion, inactivated, adjuvanted)]. Influenza pandemics, in which a new strain to which there is little or no pre-existing immunity in the human population, are impossible to predict and could cause mild, moderate or
Medgadget
AUGUST 2, 2022
Columbia University scientists and collaborators at Rover Diagnostics have created a rapid PCR test that can be used at the point of care. Weighing in at two pounds, the portable device can rival the sensitivity and accuracy of traditional lab-based PCR testing equipment, but providing results in as little as 23 minutes. The new device includes miniaturized optical components and relies on plasmonic thermocycling.
MedReps
AUGUST 2, 2022
Over the past few years, exit interviews have become the norm. Companies want to find out why their employees are leaving so they can improve their culture and retain additional workers. In order to make these important changes, they first need to spend time discussing the pros and cons of working at the company with their employee. Obviously, as they are on their way out the door, most employees are more willing to provide honest and valuable feedback.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
PharmaVoice
AUGUST 2, 2022
How Seed Health is transforming the microbiome therapeutic market with its pharma-focused drug development approach.
European Pharmaceutical Review
AUGUST 2, 2022
New Phase II data demonstrates that treatment with Biogen’s litifilimab (BIIB059) was superior in reducing skin disease activity of cutaneous lupus erythematosus (CLE) to placebo over a period of 16 weeks. The results of the Phase II LILAC study Part B were published in The New England Journal of Medicine ( NEJM ). CLE, a type of lupus, is a chronic autoimmune skin disease.
Map My Customers
AUGUST 2, 2022
Are you looking for a job that offers flexibility while earning an impressive income? If so, a career as a medical sales rep is a very good option! Medical sales can be an incredibly lucrative field. According to a study by MedReps , the leading industry website for medical sales professionals, the average yearly total compensation in 2021 for medical sales reps was $172.5k.
pharmaphorum
AUGUST 2, 2022
Sosei Heptares has signed up a string of big pharma collaborators over the last few years, and one of them – AbbVie – has just expanded its partnership with a new to deal to apply the biotech’s G protein-coupled receptor (GPCR) expertise to the discovery of drugs for neurological diseases. The collaboration adds to an earlier drug discovery agreement in the area of immunology and inflammation which dates back to June 2020, suggesting AbbVie likes what it has seen in the earlier alliance.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
PharmaTech
AUGUST 2, 2022
Successful digital transformation in biopharma requires an integrated approach to the data lifecycle.
PharmaTimes
AUGUST 2, 2022
System improves management for people with diabetes by offering finger prick-free monitoring
PharmaVoice
AUGUST 2, 2022
EverythingALS aims to speed drug development through improved diagnostics.
Pharmaceutical Technology
AUGUST 2, 2022
The Health Emergency Preparedness and Response Authority (HERA) of the European Commission (EC) has entered a co-procurement framework contract for HIPRA HUMAN HEALTH’s bivalent recombinant protein Covid-19 vaccine. A total of 14 member states and countries are participating in this deal and can procure up to 250 million vaccine doses. . Once the HIPRA vaccine receives a positive assessment from the European Medicines Agency (EMA), this contract will aid in making the doses available rapidly to
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
205 
Let's personalize your content